The purpose of this review is to describe the available evidence regarding the impact of PCI in acute HF (in the presence and absence of an acute coronary syndrome), chronic HF with reduced ejection fraction (HFrEF), and HF with preserved ejection fraction (HFpEF).

Editors

Editor-in-Chief
Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Authors
Puja B. Parikh, MD, MPH

Varun Bhasin, MD 

Javed Butler, MD, MPH, MBA

Important Dates

Date of Release: May 10, 2021
Term of Approval/Date of CME/MOC/ECME Expiration: May 9, 2022